NC Medical Marijuana Bill Passes Senate Finance Committee

Fox Rothschild LLP
Contact

Fox Rothschild LLP

On Wednesday afternoon North Carolina Senate Bill 711, the Compassionate Care Act, was approved by the Senate Finance Committee completing another step in the Bill’s journey to legalize medical marijuana in North Carolina.  The version of SB 711 the Finance Committee approved is virtually the same bill the Judiciary Committee passed a couple weeks ago.

Of note, the Finance Committee hearing included clarification regarding the 10 suppler licenses set to be given out by the Medical Cannabis Production Commission under the Bill. The North Carolina Department of Health and Human Resources will select 20 supplier applications and from those the Commission will pick 10 to issue licenses to.  The 10 license limit, which received some criticism from commentators at the hearing for constricting supply and demand, was reportedly chosen to control roll out.  Under the framework each licensee is permitted to have 4 medical cannabis centers (i.e. dispensaries) for a potential total of 40 state-wide.

Each licensee must still have two medical cannabis centers in Tier 1 counties, which are the 40 most economically distressed counties as annually designated by the North Carolina Department of Commerce.  In addition, each licensee will still be required to operate as a vertical organization, with cultivation, manufacturing/production, and dispensary/retail under the same license, which must be owned by majority NC residents.

During the hearing a significant point of discussion was the revenue side of approval, and the importance of the potential patient population in mind for an accurate revenue assessment. There are currently not specific revenue projections for the proposed medical marijuana program because state-by-state legalization varies widely and there is no uniform best practice—leaving North Carolina Senators with no fiscal comparator for revenue extrapolation.

In the end Senators voted unanimously to pass the bill.  The bill now moves to the Committee on Health and Safety which will be a major step in whether it is ultimately passed.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Fox Rothschild LLP | Attorney Advertising

Written by:

Fox Rothschild LLP
Contact
more
less

Fox Rothschild LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.